Amwill Health Care Ltd Stock Price Today (NSE: AMWILL)

Amwill Health Care Ltd

42.50+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Amwill Health Care Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Amwill Health Care Ltd share price today is 42.50, up +0.00% on NSE/BSE as of 17 September 2026. Amwill Health Care Ltd (AMWILL) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of 85.02 (Cr). The 52-week high for AMWILL share price is 62.99 and the 52-week low is 28.91. At a P/E ratio of 7.18x, AMWILL is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 15.25% and a debt-to-equity ratio of N/A.

Amwill Health Care Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
45.00
Low
41.50
Volume
14.4K
Change
+3.37%

Amwill Health Care Ltd share price chart: 3.37% return over the past month. 52-week high ₹62.99, 52-week low ₹28.91.

Amwill Health Care Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
43.5043.5042.2442.506.00K (Cr)
44.0044.0044.0044.001.20K (Cr)
41.5043.1541.5043.006.00K (Cr)
43.5143.5142.5042.907.20K (Cr)
42.7543.5142.7143.514.80K (Cr)
41.7544.5041.7542.5013.20K (Cr)
43.5043.5043.0043.009.60K (Cr)
43.5044.0043.0043.007.20K (Cr)
43.7044.0043.5043.506.00K (Cr)
43.5043.5043.5043.500.00 (Cr)

Amwill Health Care Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
43.7044.5041.5042.50-2.75%
41.5045.0039.6043.50+4.82%
43.0045.6038.6042.50-1.16%
34.3349.7534.3344.00+28.17%
35.4836.4030.6932.70-7.84%
29.5038.5028.9134.89+18.27%
33.1536.9828.9528.95-12.67%
35.9637.7934.5034.85-3.09%
48.9050.9036.2539.55-19.12%
42.0547.9434.0047.63+13.27%
56.0057.0040.0042.05-24.91%
53.3055.9650.0054.00+1.31%

Returns & Performance

Average

Return on Equity (ROE)

15.25%

Profit generated per ₹1 of shareholder equity

Good

Return on Capital (ROCE)

16.70%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

27.55%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Amwill Health Care Ltd Valuation Check

Excellent

Price to Earnings (P/E)

7.18x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

34.89x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

70.65%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

79.33%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

39.36%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

21.43%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

15.07%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

68.09%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Debt to Equity Ratio

N/A

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

15.86 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Amwill Health Care Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of AMWILL across key market metrics for learning purposes.

Positive Indicators

12 factors identified

Strong Return on Equity (15.25%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (16.70%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (27.55%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 7.18 vs Industry: 34.89)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (79.33%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (39.36%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (21.43% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (15.07% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (68.09% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Healthy Liquidity Position (Current Ratio: 11.11)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Balanced Promoter Holding (70.65%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

1 factors identified

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Amwill Health Care Ltd vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare Amwill Health Care Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
78/100
43
₹85.02
7.2
Average
15.25%
Good
16.70%
Good
68.09%
Excellent
21.43%
Excellent
0.00%
66.4/100
1852
₹444302.37
36.7
Average
14.74%
Average
19.31%
Good
0.0
Excellent
31.64%
Excellent
11.78%
Good
0.82%
56.3/100
9421
₹249656.50
85.5
Average
16.19%
Good
20.38%
Excellent
0.0
Excellent
5.29%
Good
8.67%
Good
0.41%
51.4/100
4948
₹167470.01
79.0
Average
27.07%
Excellent
14.09%
Average
1.8
Average
11.56%
Good
11.80%
Good
0.76%
74.1/100
1124
₹112195.16
25.1
Average
19.74%
Good
21.77%
Excellent
0.4
Excellent
18.76%
Excellent
12.45%
Good
0.09%
40.2/100
1372
₹110853.17
32.9
Average
11.82%
Average
15.67%
Good
0.0
Excellent
10.03%
Good
8.01%
Good
0.90%
34.1/100
1941
₹104862.52
95.8
Average
18.19%
Good
21.35%
Excellent
0.5
Excellent
-1.89%
Poor
7.19%
Good
0.13%
24.6/100
1670
₹96103.31
26.1
Average
9.94%
Poor
14.54%
Average
0.2
Excellent
-8.07%
Poor
6.32%
Good
0.26%
41/100
1137
₹94922.80
29.4
Average
11.75%
Average
14.80%
Average
0.2
Excellent
16.54%
Excellent
12.09%
Good
0.65%
83.4/100
2072
₹94719.34
17.1
Average
26.90%
Excellent
31.80%
Excellent
0.3
Excellent
34.39%
Excellent
13.02%
Good
0.72%
61.5/100
2259
₹93296.70
45.6
Average
12.49%
Average
13.56%
Average
0.4
Excellent
10.52%
Good
18.10%
Excellent
0.04%

Amwill Health Care Ltd Quarterly Performance

Latest quarterly metrics for AMWILL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

39.36%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

79.33%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

21.43%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

68.09%

Compounded annual net profit growth over 5 years

Amwill Health Care Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for AMWILL — calculated from daily price history

46RSI 14
Neutral — RSI 46

Momentum is balanced — neither overbought nor oversold.

SMA 50
43
▼ Price below SMA 50 — Short-term bearish
SMA 200
40
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
11K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Amwill Health Care Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Amwill Health Care Ltd (AMWILL) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Amwill Health Care Ltd

Loading latest quarterly results...

About AMWILL (Amwill Health Care Ltd)

Amwill Health Care Ltd is a pharmaceutical enterprise dedicated to innovating and delivering advanced healthcare solutions. With a strong commitment to research and development, AM...WILL focuses on creating novel therapeutic interventions and improving existing treatment modalities across various medical disciplines. The company is structured around a multifaceted approach, encompassing the entire lifecycle of pharmaceutical products, from initial discovery and preclinical studies to clinical trials, regulatory approvals, manufacturing, and commercialization. AMWILL's core strength lies in its team of experienced scientists, clinicians, and industry professionals who collaborate to address unmet medical needs and enhance patient outcomes. Through strategic partnerships and a continuous pursuit of scientific excellence, AMWILL strives to be a catalyst for progress in the ever-evolving landscape of healthcare. AMWILL Health Care Ltd distinguishes itself through its state-of-the-art manufacturing facilities and rigorous quality control processes, ensuring that its products consistently meet the highest standards of safety and efficacy. The company's diverse portfolio includes a wide array of pharmaceutical formulations, catering to a broad spectrum of therapeutic areas, including but not limited to, cardiovascular health, oncology, neurology, and infectious diseases. By embracing cutting-edge technologies and adhering to stringent regulatory guidelines, AMWILL ensures that its offerings are not only effective but also accessible to patients worldwide. The company actively invests in building a robust distribution network and fostering strong relationships with healthcare providers, aiming to facilitate the seamless delivery of its products to those who need them most. Amwill Health Care Ltd is dedicated to corporate social responsibility, understanding that its role extends beyond providing medicines to fostering a healthier and more sustainable future. Through various initiatives, AMWILL actively supports community health programs, promotes environmental conservation, and upholds ethical business practices. The company is committed to transparency and accountability in all its operations, striving to earn the trust and respect of its stakeholders. By prioritizing innovation, quality, and social impact, AMWILL aims to be a trusted partner in healthcare, contributing to the well-being of individuals and communities around the globe. Its overarching goal is to transform lives through its commitment to pharmaceutical excellence and responsible corporate citizenship.

Company Details

Symbol:AMWILL
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Tarun Gandhi
Chairman & MD
Mr. Anand Gandhi
MD & Director
Ms. Sharanya Nagaraj
Chief Financial Officer

AMWILL Share Price: Frequently Asked Questions

What is the current share price of Amwill Health Care Ltd?

Amwill Health Care Ltd (AMWILL) trades at ₹42.50 on NSE and BSE. Market cap ₹85.02 (Cr). Educational data only.

What is the P/E ratio of Amwill Health Care Ltd?

Amwill Health Care Ltd has a P/E of 7.18x vs industry average 34.89x.

What is the Bull Run score for Amwill Health Care Ltd?

Amwill Health Care Ltd has a Bull Run score of 78/100 based on 25+ financial parameters.

Does Amwill Health Care Ltd pay dividends?

Amwill Health Care Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Amwill Health Care Ltd?

Amwill Health Care Ltd has ROE of 15.25%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Amwill Health Care Ltd?

Amwill Health Care Ltd has debt-to-equity of N/A.

Is Amwill Health Care Ltd a good investment?

Bull Run gives Amwill Health Care Ltd a score of 78/100. This is not investment advice — consult a SEBI-registered advisor.